Search results
Results From The WOW.Com Content Network
Ranbaxy's Malvinder Singh remained as CEO after the transaction. [11] The addition of Ranbaxy Laboratories extended Daiichi-Sankyo's operations, with the combined company worth about US$30 billion. [12] In 2009, it was reported that former Novartis Senior Vice-President Yugal Sikri would lead the Indian operations of Ranbaxy Laboratories. [13] [14]
In 2006, Advent had sold 96.7% of the company to Ranbaxy. Terapia S.A. therefore went through a brand name change, and so it became Terapia Ranbaxy. Two years later, the Japanese pharmaceutical giant Daiichi Sankyo had purchased 1/5 of the company, and so Terapia Ranbaxy became part of the giant.
You are free: to share – to copy, distribute and transmit the work; to remix – to adapt the work; Under the following conditions: attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made.
For premium support please call: 800-290-4726 more ways to reach us
The odds are high you’ve had a cough before in your life, but each time can throw you for a loop. Even though you’ve been through this, it can be hard to know when to see a doctor for a cough ...
Ranbaxy was way more than simply "laden with controversy" as currently stated in the introduction, and the Controversies section currently does not make it clear that the company's "whose business model was completely dependent on falsifying data in their drug applications to the FDA" (in the words of Katherine Eban's interviewer).
The Pop-Tarts Bowl will have not one, not two, but three edible mascots this year. (Photo by David Rosenblum/Icon Sportswire via Getty Images) (Icon Sportswire via Getty Images)
The following other wikis use this file: Usage on ar.wikipedia.org رانباكسي; Usage on azb.wikipedia.org رانباکسی لابراتورو